Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company committed to pioneering solutions to deliver life-changing brain health medicines, so every person can thrive. Many individuals and families face significant challenges due to brain health disorders, and traditional treatment approaches often fall short of providing adequate relief or come with undesirable side effects. Recognizing this unmet need, Sage has dedicated its efforts to understanding the complexities of the brain and developing innovative therapies that target the underlying mechanisms of these conditions. Our customers, including patients, their families, and healthcare providers, are at the center of everything we do. We strive to develop treatments that not only alleviate symptoms but also improve overall quality of life, allowing individuals to regain function and pursue their personal and professional aspirations.

A key area of focus for Sage has been maternal mental health, a field where there has been a profound need for new and effective treatments. We are proud to have developed the only two FDA-approved treatments specifically indicated for postpartum depression (PPD). This achievement underscores our commitment to addressing critical gaps in care and providing hope to mothers experiencing this debilitating condition. Beyond PPD, Sage is advancing a robust pipeline of potential medicines targeting a wide range of brain health disorders across depression, neurology, and neuropsychiatry. We believe that by focusing on novel mechanisms of action, such as those involving GABA and NMDA receptor systems, we can offer new therapeutic options for patients who have not found success with existing treatments. Our approach integrates the patient and care partner perspectives into every aspect of our work, from early research and clinical development through to commercialization, ensuring that our solutions are truly patient-centric and address the real-world needs of those we aim to serve. We are driven by the potential to make a meaningful difference in the lives of millions of people affected by brain health disorders.